Olema Pharmaceuticals OLMA
NASDAQ OLMA
$10.75 +0.02 (+0.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Net Equity Issued and Repurchased (2020 - 2024)

Olema Pharmaceuticals (OLMA) posted quarterly Net Equity Issued and Repurchased of $14.9 million for Q2 2024, up 88.61% quarter-over-quarter from $7.9 million in Q1 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Olema Pharmaceuticals (OLMA) Net Equity Issued and Repurchased (2020 - 2024) Analysis & Trends

Olema Pharmaceuticals (OLMA) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $14.9 million the latest figure, recorded in Q2 2024.

  • In Q2 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $14.9 million; the TTM figure through Jun 2024 stood at $57.8 million (changed N/A YoY), while the FY2024 annual figure was $22.8 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased advanced to $14.9 million in Q2 2024 per OLMA's latest filing, from $7.9 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $36.7 million in Q3 2020 and bottomed at -$1.7 million in Q4 2020.
Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Olema Pharmaceuticals 1.13 Bn 1.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 14.90 Mn
Mar 31, 2024 7.90 Mn
Dec 31, 2020 -1.65 Mn
Sep 30, 2020 36.69 Mn
Jun 30, 2020 23.75 Mn
Mar 31, 2020 26.99 Mn